Indian nutraceutical ingredient manufacturer strengthens international operations and participates in global wellness events
Zeus Hygia, an Indian nutraceutical ingredient manufacturer, announced the opening of its first office in the United States, located in Florida. The expansion aims to strengthen the company’s global footprint and improve service to key international markets.
Drawing on India’s herbal knowledge rooted in Ayurveda, Zeus Hygia develops clinically validated nutraceuticals and botanical actives for the global nutraceutical and wellness industry.
As part of its international outreach, Zeus Hygia participates in nutraceutical and functional ingredient events across Southeast Asia, Japan, and Europe to drive partnerships within the global wellness industry.
Zeus Hygia’s flagship ingredients, Grantria and Germin, received awards at the 2025 NIE New Ingredient Awards, recognising the company’s development of clinically validated herbal extracts.
The global mandate is led by Avileli Mouli Srikar, who has experience in the health and wellness sector across APAC, MENA, and ASEAN regions. Mouli has worked with companies including AKAY Bioactives, Natural Remedies, Anthem Biosciences, and Sami-Sabinsa Group.
“Our vision has always been to make evidence-based natural wellness accessible to the world,” said Avileli Mouli Srikar, Head of Global Business, Zeus Hygia. “The US office launch is a significant step towards strengthening our presence in one of the most dynamic nutraceutical markets globally. We’re excited to build new collaborations and bring our innovations closer to partners and consumers worldwide.”
Zeus Hygia is conducting clinical trials for a new portfolio of next-generation nutraceutical ingredients and plans further developments in its innovation pipeline, aiming to contribute to the global nutraceutical industry.
